Patent Landscape
Diabetes, cancer still top areas for innovation: U.S. pharmaceuticals patent landscape report
Our analysis of the U.S. pharmaceutical patent landscape in 2023 reveals that diseases like diabetes, respiratory conditions, and cancer remain at the forefront innovation. These
February 6, 2024
